Literature DB >> 35302258

Immunomodulatory effects of curcumin in systemic autoimmune diseases.

Sajjad Chamani1,2, Maryam Moossavi3, Ali Naghizadeh1, Mitra Abbasifard4,5, Muhammed Majeed6, Thomas P Johnston7, Amirhossein Sahebkar8,9,10,11.   

Abstract

Systemic autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus represent various autoimmune conditions identified by immune system dysregulation. The activation of immune cells, auto-antigen outbreak, inflammation, and multi-organ impairment is observed in these disorders. The immune system is an essential complex network of cells and chemical mediators which defends the organism's integrity against foreign microorganisms, and its precise operation and stability are compulsory to avoid a wide range of medical complications. Curcumin is a phenolic ingredient extracted from turmeric and belongs to the Zingiberaceae, or ginger family. Curcumin has multiple functions, such as inhibiting inflammation, oxidative stress, tumor cell proliferation, cell death, and infection. Nevertheless, the immunomodulatory influence of curcumin on immunological reactions/processes remains mostly unknown. In the present narrative review, we sought to provide current information concerning the preclinical and clinical uses of curcumin in systemic autoimmune diseases.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  curcumin; immunomodulatory effect; inflammation; systemic autoimmune diseases

Mesh:

Substances:

Year:  2022        PMID: 35302258     DOI: 10.1002/ptr.7417

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  1 in total

1.  The Impact of the Oil Phase Selection on Physicochemical Properties, Long-Term Stability, In Vitro Performance and Injectability of Curcumin-Loaded PEGylated Nanoemulsions.

Authors:  Jelena B Đoković; Sotiria Demisli; Sanela M Savić; Bojan D Marković; Nebojša D Cekić; Danijela V Randjelovic; Jelena R Mitrović; Dominique Jasmin Lunter; Vassiliki Papadimitriou; Aristotelis Xenakis; Snežana D Savić
Journal:  Pharmaceutics       Date:  2022-08-10       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.